APO Research, Inc.

APO RESEARCH · REPORT

Tumor Gene Test Service

Selected research

Industry Growth & Trends

Global Tumor Gene Test Service Industry Growth and Trends Forecast to 2032

Market perspective

According to APO Research, the global Tumor Gene Test Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Tumor Gene Test Service is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Tumor Gene Test Service is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Tumor Gene Test Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Tumor Gene Test Service market include Illumina, BGI Genomics Co.,Ltd., Agilent Technologies, Macrogen, Pacific Biosciences, 10x Genomics, QIAGEN, GEEWIZ and MACROGEN, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Tumor Gene Test Service market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Tumor Gene Test Service market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Tumor Gene Test Service market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Tumor Gene Test Service.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Tumor Gene Test Service market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Tumor Gene Test Service Market by Company

Illumina

BGI Genomics Co.,Ltd.

Agilent Technologies

Macrogen

Pacific Biosciences

10x Genomics

QIAGEN

GEEWIZ

MACROGEN

Oxford Nanopore Technologies

Tumor Gene Test Service Segment by Type

Tumor Tissue

Blood

Tumor Gene Test Service Segment by Application

Medical Institution

Scientific Research Institutions

Pharmaceutical Companies

Individual User

Tumor Gene Test Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tumor Gene Test Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Tumor Gene Test Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tumor Gene Test Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Tumor Gene Test Service companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Tumor Gene Test Service Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Tumor Gene Test Service Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Tumor Gene Test Service Market Share by Region (2021-2026) Table 4. Global Tumor Gene Test Service Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Tumor Gene Test Service Market Share by Region (2027-2032) Table 6. Global Tumor Gene Test Service Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Tumor Gene Test Service Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Tumor Gene Test Service Market Size Share by Type (2021-2026) Table 9. Global Tumor Gene Test Service Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Tumor Gene Test Service Market Size Share Forecasted by Type (2027-2032) Table 11. North America Tumor Gene Test Service Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Tumor Gene Test Service Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Tumor Gene Test Service Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Tumor Gene Test Service Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Tumor Gene Test Service Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Tumor Gene Test Service Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Tumor Gene Test Service Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Tumor Gene Test Service Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Tumor Gene Test Service Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Tumor Gene Test Service Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Tumor Gene Test Service Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Tumor Gene Test Service Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Tumor Gene Test Service Market Size Share by Application (2021-2026) Table 24. Global Tumor Gene Test Service Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Tumor Gene Test Service Market Size Share Forecasted by Application (2027-2032) Table 26. North America Tumor Gene Test Service Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Tumor Gene Test Service Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Tumor Gene Test Service Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Tumor Gene Test Service Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Tumor Gene Test Service Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Tumor Gene Test Service Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Tumor Gene Test Service Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Tumor Gene Test Service Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Tumor Gene Test Service Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Tumor Gene Test Service Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Tumor Gene Test Service Industry Trends Table 37. Tumor Gene Test Service Industry Drivers Table 38. Tumor Gene Test Service Industry Opportunities and Challenges Table 39. Tumor Gene Test Service Industry Restraints Table 40. Global Tumor Gene Test Service Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Tumor Gene Test Service Revenue Market Share by Company (2021-2026) Table 42. Global Tumor Gene Test Service Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Tumor Gene Test Service Key Company Headquarters & Area Served Table 44. Global Tumor Gene Test Service Company, Product Type & Application Table 45. Global Tumor Gene Test Service Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Tumor Gene Test Service by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Illumina Company Information Table 49. Illumina Business Overview Table 50. Illumina Tumor Gene Test Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Illumina Tumor Gene Test Service Product Portfolio Table 52. Illumina Recent Development Table 53. BGI Genomics Co.,Ltd. Company Information Table 54. BGI Genomics Co.,Ltd. Business Overview Table 55. BGI Genomics Co.,Ltd. Tumor Gene Test Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. BGI Genomics Co.,Ltd. Tumor Gene Test Service Product Portfolio Table 57. BGI Genomics Co.,Ltd. Recent Development Table 58. Agilent Technologies Company Information Table 59. Agilent Technologies Business Overview Table 60. Agilent Technologies Tumor Gene Test Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Agilent Technologies Tumor Gene Test Service Product Portfolio Table 62. Agilent Technologies Recent Development Table 63. Macrogen Company Information Table 64. Macrogen Business Overview Table 65. Macrogen Tumor Gene Test Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Macrogen Tumor Gene Test Service Product Portfolio Table 67. Macrogen Recent Development Table 68. Pacific Biosciences Company Information Table 69. Pacific Biosciences Business Overview Table 70. Pacific Biosciences Tumor Gene Test Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Pacific Biosciences Tumor Gene Test Service Product Portfolio Table 72. Pacific Biosciences Recent Development Table 73. 10x Genomics Company Information Table 74. 10x Genomics Business Overview Table 75. 10x Genomics Tumor Gene Test Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. 10x Genomics Tumor Gene Test Service Product Portfolio Table 77. 10x Genomics Recent Development Table 78. QIAGEN Company Information Table 79. QIAGEN Business Overview Table 80. QIAGEN Tumor Gene Test Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. QIAGEN Tumor Gene Test Service Product Portfolio Table 82. QIAGEN Recent Development Table 83. GEEWIZ Company Information Table 84. GEEWIZ Business Overview Table 85. GEEWIZ Tumor Gene Test Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. GEEWIZ Tumor Gene Test Service Product Portfolio Table 87. GEEWIZ Recent Development Table 88. MACROGEN Company Information Table 89. MACROGEN Business Overview Table 90. MACROGEN Tumor Gene Test Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. MACROGEN Tumor Gene Test Service Product Portfolio Table 92. MACROGEN Recent Development Table 93. Oxford Nanopore Technologies Company Information Table 94. Oxford Nanopore Technologies Business Overview Table 95. Oxford Nanopore Technologies Tumor Gene Test Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Oxford Nanopore Technologies Tumor Gene Test Service Product Portfolio Table 97. Oxford Nanopore Technologies Recent Development Table 98. North America Tumor Gene Test Service Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 99. North America Tumor Gene Test Service Market Size by Country (2021-2026) & (US$ Million) Table 100. North America Tumor Gene Test Service Market Share by Country (2021-2026) Table 101. North America Tumor Gene Test Service Market Size Forecast by Country (2027-2032) & (US$ Million) Table 102. North America Tumor Gene Test Service Market Share Forecast by Country (2027-2032) Table 103. Europe Tumor Gene Test Service Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 104. Europe Tumor Gene Test Service Market Size by Country (2021-2026) & (US$ Million) Table 105. Europe Tumor Gene Test Service Market Share by Country (2021-2026) Table 106. Europe Tumor Gene Test Service Market Size Forecast by Country (2027-2032) & (US$ Million) Table 107. Europe Tumor Gene Test Service Market Share Forecast by Country (2027-2032) Table 108. Asia-Pacific Tumor Gene Test Service Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 109. Asia-Pacific Tumor Gene Test Service Market Size by Country (2021-2026) & (US$ Million) Table 110. Asia-Pacific Tumor Gene Test Service Market Share by Country (2021-2026) Table 111. Asia-Pacific Tumor Gene Test Service Market Size Forecast by Country (2027-2032) & (US$ Million) Table 112. Asia-Pacific Tumor Gene Test Service Market Share Forecast by Country (2027-2032) Table 113. Latin America Tumor Gene Test Service Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 114. Latin America Tumor Gene Test Service Market Size by Country (2021-2026) & (US$ Million) Table 115. Latin America Tumor Gene Test Service Market Share by Country (2021-2026) Table 116. Latin America Tumor Gene Test Service Market Size Forecast by Country (2027-2032) & (US$ Million) Table 117. Latin America Tumor Gene Test Service Market Share Forecast by Country (2027-2032) Table 118. Middle East & Africa Tumor Gene Test Service Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 119. Middle East & Africa Tumor Gene Test Service Market Size by Country (2021-2026) & (US$ Million) Table 120. Middle East & Africa Tumor Gene Test Service Market Share by Country (2021-2026) Table 121. Middle East & Africa Tumor Gene Test Service Market Size Forecast by Country (2027-2032) & (US$ Million) Table 122. Middle East & Africa Tumor Gene Test Service Market Share Forecast by Country (2027-2032) Table 123. Research Programs/Design for This Report Table 124. Authors List of This Report Table 125. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Tumor Gene Test Service Product Image Figure 3. Global Tumor Gene Test Service Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Tumor Gene Test Service Market Size (2021-2032) & (US$ Million) Figure 5. Global Tumor Gene Test Service Market Share by Region: 2025 VS 2032 Figure 6. Global Tumor Gene Test Service Market Share by Region (2021-2032) Figure 7. North America Tumor Gene Test Service Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Tumor Gene Test Service Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Tumor Gene Test Service Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Tumor Gene Test Service Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Tumor Gene Test Service Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Tumor Tissue Image Figure 13. Global Tumor Tissue Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Blood Image Figure 15. Global Blood Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Global Tumor Gene Test Service Market Size Overview by Type (2021-2032) & (US$ Million) Figure 17. Global Tumor Gene Test Service Market Share by Type 2025 VS 2032 Figure 18. North America Tumor Gene Test Service Market Size Share by Type (2021-2032) Figure 19. Europe Tumor Gene Test Service Market Size Share by Type (2021-2032) Figure 20. Asia-Pacific Tumor Gene Test Service Market Size Share by Type (2021-2032) Figure 21. Latin America Tumor Gene Test Service Market Size Share by Type (2021-2032) Figure 22. Middle East and Africa Tumor Gene Test Service Market Size Share by Type (2021-2032) Figure 23. Medical Institution Image Figure 24. Global Medical Institution Market Size YoY Growth (2021-2032) & (US$ Million) Figure 25. Scientific Research Institutions Image Figure 26. Global Scientific Research Institutions Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Pharmaceutical Companies Image Figure 28. Global Pharmaceutical Companies Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Individual User Image Figure 30. Global Individual User Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Global Tumor Gene Test Service Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Tumor Gene Test Service Market Share by Application 2025 VS 2032 Figure 33. North America Tumor Gene Test Service Market Size Share by Application (2021-2032) Figure 34. Europe Tumor Gene Test Service Market Size Share by Application (2021-2032) Figure 35. Asia-Pacific Tumor Gene Test Service Market Size Share by Application (2021-2032) Figure 36. Latin America Tumor Gene Test Service Market Size Share by Application (2021-2032) Figure 37. Middle East and Africa Tumor Gene Test Service Market Size Share by Application (2021-2032) Figure 38. Global Top 5 and 10 Tumor Gene Test Service Players Market Share by Revenue in 2025 Figure 39. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 40. North America Tumor Gene Test Service Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 41. North America Tumor Gene Test Service Market Share by Country: 2021 VS 2025 VS 2032 Figure 42. North America Tumor Gene Test Service Market Share by Country (2021-2032) Figure 43. Europe Tumor Gene Test Service Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. Europe Tumor Gene Test Service Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Tumor Gene Test Service Market Share by Country (2021-2032) Figure 46. Asia-Pacific Tumor Gene Test Service Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 47. Asia-Pacific Tumor Gene Test Service Market Share by Country: 2021 VS 2025 VS 2032 Figure 48. Asia-Pacific Tumor Gene Test Service Market Share by Country (2021-2032) Figure 49. Latin America Tumor Gene Test Service Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Latin America Tumor Gene Test Service Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Tumor Gene Test Service Market Share by Country (2021-2032) Figure 52. Middle East & Africa Tumor Gene Test Service Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 53. Middle East & Africa Tumor Gene Test Service Market Share by Country: 2021 VS 2025 VS 2032 Figure 54. Middle East & Africa Tumor Gene Test Service Market Share by Country (2021-2032) Figure 55. Years Considered Figure 56. Research Process Figure 57. Key Executives Interviewed

Scope & coverage.

Types
  • Tumor Tissue
  • Blood
Applications
  • Medical Institution
  • Scientific Research Institutions
  • Pharmaceutical Companies
  • Individual User
Companies covered
  • Illumina
  • BGI Genomics Co.,Ltd.
  • Agilent Technologies
  • Macrogen
  • Pacific Biosciences
  • 10x Genomics
  • QIAGEN
  • GEEWIZ
  • MACROGEN
  • Oxford Nanopore Technologies

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Tumor Gene Test Service Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Tumor Gene Test Service Market Size by Region (2021-2032)
  5. 1.4.1 Global Tumor Gene Test Service Market Size by Region (2021-2026)
  6. 1.4.2 Global Tumor Gene Test Service Market Size by Region (2027-2032)
  7. 1.5 Key Regions Tumor Gene Test Service Market Size (2021-2032)
  8. 1.5.1 North America Tumor Gene Test Service Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Tumor Gene Test Service Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Tumor Gene Test Service Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Tumor Gene Test Service Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Tumor Gene Test Service Market Size Growth Rate (2021-2032)
2 Tumor Gene Test Service Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Tumor Tissue
  3. 2.1.2 Blood
  4. 2.2 Global Tumor Gene Test Service Market Size by Type
  5. 2.2.1 Global Tumor Gene Test Service Market Size Overview by Type (2021-2032)
  6. 2.2.2 Global Tumor Gene Test Service Historic Market Size Review by Type (2021-2026)
  7. 2.2.3 Global Tumor Gene Test Service Market Size Forecasted by Type (2027-2032)
  8. 2.3 Global Tumor Gene Test Service Market Size by Regions
  9. 2.3.1 North America Tumor Gene Test Service Market Size Breakdown by Type (2021-2026)
  10. 2.3.2 Europe Tumor Gene Test Service Market Size Breakdown by Type (2021-2026)
  11. 2.3.3 Asia-Pacific Tumor Gene Test Service Market Size Breakdown by Type (2021-2026)
  12. 2.3.4 South America Tumor Gene Test Service Market Size Breakdown by Type (2021-2026)
  13. 2.3.5 Middle East and Africa Tumor Gene Test Service Market Size Breakdown by Type (2021-2026)
3 Tumor Gene Test Service Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Medical Institution
  3. 3.1.2 Scientific Research Institutions
  4. 3.1.3 Pharmaceutical Companies
  5. 3.1.4 Individual User
  6. 3.2 Global Tumor Gene Test Service Market Size by Application
  7. 3.2.1 Global Tumor Gene Test Service Market Size Overview by Application (2021-2032)
  8. 3.2.2 Global Tumor Gene Test Service Historic Market Size Review by Application (2021-2026)
  9. 3.2.3 Global Tumor Gene Test Service Market Size Forecasted by Application (2027-2032)
  10. 3.3 Global Tumor Gene Test Service Market Size by Regions
  11. 3.3.1 North America Tumor Gene Test Service Market Size Breakdown by Application (2021-2026)
  12. 3.3.2 Europe Tumor Gene Test Service Market Size Breakdown by Application (2021-2026)
  13. 3.3.3 Asia-Pacific Tumor Gene Test Service Market Size Breakdown by Application (2021-2026)
  14. 3.3.4 South America Tumor Gene Test Service Market Size Breakdown by Application (2021-2026)
  15. 3.3.5 Middle East and Africa Tumor Gene Test Service Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Tumor Gene Test Service Industry Trends
  2. 4.2 Tumor Gene Test Service Industry Drivers
  3. 4.3 Tumor Gene Test Service Industry Opportunities and Challenges
  4. 4.4 Tumor Gene Test Service Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Tumor Gene Test Service Revenue (2021-2026)
  2. 5.2 Global Tumor Gene Test Service Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Tumor Gene Test Service Key Company Headquarters & Area Served
  4. 5.4 Global Tumor Gene Test Service Company, Product Type & Application
  5. 5.5 Global Tumor Gene Test Service Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Tumor Gene Test Service Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Tumor Gene Test Service Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Tumor Gene Test Service Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Illumina
  2. 6.1.1 Illumina Company Information
  3. 6.1.2 Illumina Business Overview
  4. 6.1.3 Illumina Tumor Gene Test Service Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Illumina Tumor Gene Test Service Product Portfolio
  6. 6.1.5 Illumina Recent Developments
  7. 6.2 BGI Genomics Co.,Ltd.
  8. 6.2.1 BGI Genomics Co.,Ltd. Company Information
  9. 6.2.2 BGI Genomics Co.,Ltd. Business Overview
  10. 6.2.3 BGI Genomics Co.,Ltd. Tumor Gene Test Service Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 BGI Genomics Co.,Ltd. Tumor Gene Test Service Product Portfolio
  12. 6.2.5 BGI Genomics Co.,Ltd. Recent Developments
  13. 6.3 Agilent Technologies
  14. 6.3.1 Agilent Technologies Company Information
  15. 6.3.2 Agilent Technologies Business Overview
  16. 6.3.3 Agilent Technologies Tumor Gene Test Service Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Agilent Technologies Tumor Gene Test Service Product Portfolio
  18. 6.3.5 Agilent Technologies Recent Developments
  19. 6.4 Macrogen
  20. 6.4.1 Macrogen Company Information
  21. 6.4.2 Macrogen Business Overview
  22. 6.4.3 Macrogen Tumor Gene Test Service Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Macrogen Tumor Gene Test Service Product Portfolio
  24. 6.4.5 Macrogen Recent Developments
  25. 6.5 Pacific Biosciences
  26. 6.5.1 Pacific Biosciences Company Information
  27. 6.5.2 Pacific Biosciences Business Overview
  28. 6.5.3 Pacific Biosciences Tumor Gene Test Service Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Pacific Biosciences Tumor Gene Test Service Product Portfolio
  30. 6.5.5 Pacific Biosciences Recent Developments
  31. 6.6 10x Genomics
  32. 6.6.1 10x Genomics Company Information
  33. 6.6.2 10x Genomics Business Overview
  34. 6.6.3 10x Genomics Tumor Gene Test Service Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 10x Genomics Tumor Gene Test Service Product Portfolio
  36. 6.6.5 10x Genomics Recent Developments
  37. 6.7 QIAGEN
  38. 6.7.1 QIAGEN Company Information
  39. 6.7.2 QIAGEN Business Overview
  40. 6.7.3 QIAGEN Tumor Gene Test Service Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 QIAGEN Tumor Gene Test Service Product Portfolio
  42. 6.7.5 QIAGEN Recent Developments
  43. 6.8 GEEWIZ
  44. 6.8.1 GEEWIZ Company Information
  45. 6.8.2 GEEWIZ Business Overview
  46. 6.8.3 GEEWIZ Tumor Gene Test Service Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 GEEWIZ Tumor Gene Test Service Product Portfolio
  48. 6.8.5 GEEWIZ Recent Developments
  49. 6.9 MACROGEN
  50. 6.9.1 MACROGEN Company Information
  51. 6.9.2 MACROGEN Business Overview
  52. 6.9.3 MACROGEN Tumor Gene Test Service Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 MACROGEN Tumor Gene Test Service Product Portfolio
  54. 6.9.5 MACROGEN Recent Developments
  55. 6.10 Oxford Nanopore Technologies
  56. 6.10.1 Oxford Nanopore Technologies Company Information
  57. 6.10.2 Oxford Nanopore Technologies Business Overview
  58. 6.10.3 Oxford Nanopore Technologies Tumor Gene Test Service Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Oxford Nanopore Technologies Tumor Gene Test Service Product Portfolio
  60. 6.10.5 Oxford Nanopore Technologies Recent Developments
7 North America
  1. 7.1 North America Tumor Gene Test Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Tumor Gene Test Service Market Size by Country (2021-2026)
  3. 7.3 North America Tumor Gene Test Service Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Tumor Gene Test Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Tumor Gene Test Service Market Size by Country (2021-2026)
  3. 8.3 Europe Tumor Gene Test Service Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Tumor Gene Test Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Tumor Gene Test Service Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Tumor Gene Test Service Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Tumor Gene Test Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Tumor Gene Test Service Market Size by Country (2021-2026)
  3. 10.3 South America Tumor Gene Test Service Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Tumor Gene Test Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Tumor Gene Test Service Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Tumor Gene Test Service Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.